Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors

NCT07139067 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT07139067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07139067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study of YK1101 Injection for the Treatment of Advanced Solid Tumors
Lead sponsor
Peking University
Phase
Phase 1
Overall status
Recruiting
Start date
April 27, 2025
Completion date
July 1, 2028
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor cancer